 Connection
Michel Chonchol to Kidney Failure, Chronic
This is a "connection" page, showing publications Michel Chonchol has written about Kidney Failure, Chronic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
7.622 |
|
|
|
-
Danese MD, Lubeck D, Belozeroff V, Lin TC, Desai P, Gleeson M, Martin K, Chonchol M. Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients. Am J Nephrol. 2020; 51(10):815-822.
Score: 0.502
-
Gitomer B, Pereira R, Salusky IB, Stoneback JW, Isakova T, Cai X, Dalrymple LS, Ofsthun N, You Z, Malluche HH, Maddux F, George D, Torres V, Chapman A, Steinman TI, Wolf M, Chonchol M. Mineral bone disease in autosomal dominant polycystic kidney disease. Kidney Int. 2021 04; 99(4):977-985.
Score: 0.500
-
Kendrick J, Chonchol M. Novel Therapeutic Options for the Treatment of Mineral Metabolism Abnormalities in End Stage Renal Disease. Semin Dial. 2015 Nov-Dec; 28(6):610-9.
Score: 0.352
-
Jablonski KL, Chonchol M. Posthemodialysis weights and mortality: another narrow range target? Clin J Am Soc Nephrol. 2015 May 07; 10(5):729-31.
Score: 0.344
-
Jablonski KL, Chonchol M. Vascular calcification in end-stage renal disease. Hemodial Int. 2013 Oct; 17 Suppl 1:S17-21.
Score: 0.309
-
Jablonski KL, Chonchol M. Frequent hemodialysis: a way to improve physical function? Clin J Am Soc Nephrol. 2012 May; 7(5):707-10.
Score: 0.280
-
Kendrick J, Shlipak MG, Targher G, Cook T, Lindenfeld J, Chonchol M. Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study. Am J Kidney Dis. 2010 Jan; 55(1):42-9.
Score: 0.237
-
Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease. Am J Nephrol. 2009; 30(1):64-72.
Score: 0.224
-
Chonchol M, Locatelli F, Abboud HE, Charytan C, de Francisco AL, Jolly S, Kaplan M, Roger SD, Sarkar S, Albizem MB, Mix TC, Kubo Y, Block GA. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Am J Kidney Dis. 2009 Feb; 53(2):197-207.
Score: 0.222
-
Kendrick J, Chonchol M. Renal artery stenosis and chronic ischemic nephropathy: epidemiology and diagnosis. Adv Chronic Kidney Dis. 2008 Oct; 15(4):355-62.
Score: 0.219
-
Chonchol M, Gnahn H, Sander D. Impact of subclinical carotid atherosclerosis on incident chronic kidney disease in the elderly. Nephrol Dial Transplant. 2008 Aug; 23(8):2593-8.
Score: 0.211
-
Furgeson SB, Chonchol M. Beta-blockade in chronic dialysis patients. Semin Dial. 2008 Jan-Feb; 21(1):43-8.
Score: 0.208
-
Chonchol M, Whittle J, Desbien A, Orner MB, Petersen LA, Kressin NR. Chronic kidney disease is associated with angiographic coronary artery disease. Am J Nephrol. 2008; 28(2):354-60.
Score: 0.206
-
Chonchol M, Goldenberg I, Moss AJ, McNitt S, Cheung AK. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction. Am J Nephrol. 2007; 27(1):7-14.
Score: 0.194
-
Lee W, Campoy S, Smits G, Vu Tran Z, Chonchol M. Effectiveness of a chronic kidney disease clinic in achieving K/DOQI guideline targets at initiation of dialysis--a single-centre experience. Nephrol Dial Transplant. 2007 Mar; 22(3):833-8.
Score: 0.192
-
Chonchol M, Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int. 2007 Jan; 71(2):134-9.
Score: 0.191
-
Spiegel DM, Casey L, Bell S, Parker M, Chonchol M. Achieving targets for bone and mineral metabolism: the impact of cinacalcet HCl in clinical practice. Hemodial Int. 2006 Oct; 10 Suppl 2:S24-7.
Score: 0.190
-
Chonchol M. Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial. 2006 Jul-Aug; 19(4):291-6.
Score: 0.187
-
Rizzolo K, Gonzalez Jauregui R, Barrientos I, Teakell J, Camacho C, Chonchol M, Waikar SS, Cervantes L. Barriers and Facilitators to Home Dialysis Among Latinx Patients with Kidney Disease. JAMA Netw Open. 2023 08 01; 6(8):e2328944.
Score: 0.153
-
Cervantes L, Rizzolo K, Carr AL, Steiner JF, Chonchol M, Powe N, Cukor D, Hasnain-Wynia R. Social and Cultural Challenges in Caring for Latinx Individuals With Kidney Failure in Urban Settings. JAMA Netw Open. 2021 09 01; 4(9):e2125838.
Score: 0.134
-
Pergola PE, Devalaraja M, Fishbane S, Chonchol M, Mathur VS, Smith MT, Lo L, Herzog K, Kakkar R, Davidson MH. Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. J Am Soc Nephrol. 2021 01; 32(1):211-222.
Score: 0.127
-
Cervantes L, Hasnain-Wynia R, Steiner JF, Chonchol M, Fischer S. Patient Navigation: Addressing Social Challenges in Dialysis Patients. Am J Kidney Dis. 2020 07; 76(1):121-129.
Score: 0.117
-
Jovanovich A, You Z, Isakova T, Nowak K, Cheung A, Wolf M, Chonchol M, Kendrick J. Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study. Am J Nephrol. 2019; 49(4):263-270.
Score: 0.112
-
Cervantes L, Chonchol M, Hasnain-Wynia R, Steiner JF, Havranek E, Hull M, Rice J, Kendrick J, Alamillo X, Camacho C, Fischer S. Peer Navigator Intervention for Latinos on Hemodialysis: A Single-Arm Clinical Trial. J Palliat Med. 2019 07; 22(7):838-843.
Score: 0.112
-
Melamed ML, Chonchol M, Guti?rrez OM, Kalantar-Zadeh K, Kendrick J, Norris K, Scialla JJ, Thadhani R. The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2018 12; 72(6):834-845.
Score: 0.109
-
Cervantes L, O'Hare A, Chonchol M, Hull M, Van Bockern J, Thompson M, Zoucha J. Circumstances of Death among Undocumented Immigrants Who Rely on Emergency-Only Hemodialysis. Clin J Am Soc Nephrol. 2018 09 07; 13(9):1405-1406.
Score: 0.108
-
Cervantes L, Hull M, Keniston A, Chonchol M, Hasnain-Wynia R, Fischer S. Symptom Burden among Latino Patients with End-Stage Renal Disease and Access to Standard or Emergency-Only Hemodialysis. J Palliat Med. 2018 09; 21(9):1329-1333.
Score: 0.107
-
Nowak KL, Chonchol M, You Z, Gupta M, Gitomer B. Affected parent sex and severity of autosomal dominant polycystic kidney disease: a retrospective cohort study?. Clin Nephrol. 2018 Mar; 89(3):196-204.
Score: 0.105
-
Chonchol M, Gitomer B, Isakova T, Cai X, Salusky I, Pereira R, Abebe K, Torres V, Steinman TI, Grantham JJ, Chapman AB, Schrier RW, Wolf M. Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2017 Sep 07; 12(9):1461-1469.
Score: 0.100
-
Marcuccilli M, Chonchol M, Jovanovich A. Phosphate Binders and Targets Over Decades: Do We have it Right Now? Semin Dial. 2017 03; 30(2):134-141.
Score: 0.097
-
Nowak KL, Cadnapaphornchai MA, Chonchol MB, Schrier RW, Gitomer B. Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease. Am J Nephrol. 2016; 44(3):171-8.
Score: 0.094
-
Jovanovich A, Chonchol M. Calcific Uremic Arteriolopathy Revisited. J Am Soc Nephrol. 2016 11; 27(11):3233-3235.
Score: 0.093
-
Jovanovich AJ, Chonchol MB, Sobhi A, Kendrick JB, Cheung AK, Kaufman JS, Smits G, Jablonski KL. Mineral Metabolites, Angiotensin II Inhibition and Outcomes in Advanced Chronic Kidney Disease. Am J Nephrol. 2015; 42(5):361-8.
Score: 0.090
-
de Boer IH, Sachs MC, Chonchol M, Himmelfarb J, Hoofnagle AN, Ix JH, Kremsdorf RA, Lin YS, Mehrotra R, Robinson-Cohen C, Siscovick DS, Steffes MW, Thummel KE, Tracy RP, Wang Z, Kestenbaum B. Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials. Am J Kidney Dis. 2014 Aug; 64(2):187-97.
Score: 0.080
-
Himmelfarb J, Ikizler TA, Ellis C, Wu P, Shintani A, Dalal S, Kaplan M, Chonchol M, Hakim RM. Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial. J Am Soc Nephrol. 2014 Mar; 25(3):623-33.
Score: 0.079
-
Montford JR, Chonchol M, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Kendrick J. Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23. Am J Nephrol. 2013; 37(3):183-90.
Score: 0.074
-
W?thrich RP, Chonchol M, Covic A, Gaillard S, Chong E, Tumlin JA. Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients. Clin J Am Soc Nephrol. 2013 Feb; 8(2):280-9.
Score: 0.073
-
Jovanovich A, Chonchol M, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Kendrick J. Racial differences in markers of mineral metabolism in advanced chronic kidney disease. Clin J Am Soc Nephrol. 2012 Apr; 7(4):640-7.
Score: 0.069
-
Zoppini G, Targher G, Chonchol M, Ortalda V, Abaterusso C, Pichiri I, Negri C, Bonora E. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care. 2012 Jan; 35(1):99-104.
Score: 0.068
-
Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol M. FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol. 2011 Oct; 22(10):1913-22.
Score: 0.067
-
De Graauw J, Chonchol M, Poppert H, Etgen T, Sander D. Relationship between kidney function and risk of asymptomatic peripheral arterial disease in elderly subjects. Nephrol Dial Transplant. 2011 Mar; 26(3):927-32.
Score: 0.062
-
Jalal DI, Chonchol M, Targher G. Disorders of hemostasis associated with chronic kidney disease. Semin Thromb Hemost. 2010 Feb; 36(1):34-40.
Score: 0.061
-
Targher G, Bertolini L, Chonchol M, Rodella S, Zoppini G, Lippi G, Zenari L, Bonora E. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia. 2010 Jul; 53(7):1341-8.
Score: 0.061
-
van Kuijk JP, Flu WJ, Chonchol M, Welten GM, Verhagen HJ, Bax JJ, Poldermans D. The prevalence and prognostic implications of polyvascular atherosclerotic disease in patients with chronic kidney disease. Nephrol Dial Transplant. 2010 Jun; 25(6):1882-8.
Score: 0.060
-
Zoppini G, Targher G, Chonchol M, Negri C, Stoico V, Pichiri I, Lippi G, Muggeo M, Bonora E. Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients. Atherosclerosis. 2010 Jun; 210(2):575-80.
Score: 0.059
-
Targher G, Chonchol M, Zoppini G, Salvagno G, Pichiri I, Franchini M, Lippi G. Prevalence of thyroid autoimmunity and subclinical hypothyroidism in persons with chronic kidney disease not requiring chronic dialysis. Clin Chem Lab Med. 2009; 47(11):1367-71.
Score: 0.056
-
Targher G, Chonchol M, Bertolini L, Rodella S, Zenari L, Lippi G, Franchini M, Zoppini G, Muggeo M. Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol. 2008 Aug; 19(8):1564-70.
Score: 0.053
-
Welten GM, Chonchol M, Hoeks SE, Schouten O, Dunkelgr?n M, van Gestel YR, Goei D, Bax JJ, van Domburg RT, Poldermans D. Statin therapy is associated with improved outcomes in vascular surgery patients with renal impairment. Am Heart J. 2007 Nov; 154(5):954-61.
Score: 0.051
-
Spiegel DM, Farmer B, Smits G, Chonchol M. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study. J Ren Nutr. 2007 Nov; 17(6):416-22.
Score: 0.051
-
Feringa HH, Karagiannis SE, Chonchol M, Vidakovic R, Noordzij PG, Elhendy A, van Domburg RT, Welten G, Schouten O, Bax JJ, Berl T, Poldermans D. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors. J Am Soc Nephrol. 2007 Jun; 18(6):1872-9.
Score: 0.050
-
Cho Y, Rangan G, Logeman C, Ryu H, Sautenet B, Perrone RD, Nadeau-Fredette AC, Mustafa RA, Htay H, Chonchol M, Harris T, Gutman T, Craig JC, Ong ACM, Chapman A, Ahn C, Coolican H, Kao JT, Gansevoort RT, Torres V, Pei Y, Johnson DW, Viecelli AK, Teixeira-Pinto A, Howell M, Ju A, Manera KE, Tong A. Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey. Am J Kidney Dis. 2020 09; 76(3):361-373.
Score: 0.030
-
Andrews ES, Perrenoud L, Nowak KL, You Z, Pasch A, Chonchol M, Kendrick J, Jalal D. Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial. PLoS One. 2018; 13(10):e0205831.
Score: 0.027
-
Cervantes L, Richardson S, Raghavan R, Hou N, Hasnain-Wynia R, Wynia MK, Kleiner C, Chonchol M, Tong A. Clinicians' Perspectives on Providing Emergency-Only Hemodialysis to Undocumented Immigrants: A Qualitative Study. Ann Intern Med. 2018 07 17; 169(2):78-86.
Score: 0.027
-
Cheung AK, Rahman M, Reboussin DM, Craven TE, Greene T, Kimmel PL, Cushman WC, Hawfield AT, Johnson KC, Lewis CE, Oparil S, Rocco MV, Sink KM, Whelton PK, Wright JT, Basile J, Beddhu S, Bhatt U, Chang TI, Chertow GM, Chonchol M, Freedman BI, Haley W, Ix JH, Katz LA, Killeen AA, Papademetriou V, Ricardo AC, Servilla K, Wall B, Wolfgram D, Yee J. Effects of Intensive BP Control in CKD. J Am Soc Nephrol. 2017 Sep; 28(9):2812-2823.
Score: 0.025
-
Kendrick J, Chonchol M, Gnahn H, Sander D. Higher systolic blood pressure is associated with progression of carotid intima-media thickness in patients with chronic kidney disease. Kidney Int. 2010 May; 77(9):794-800.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|